Tag: biotechnology
-
Resistant Fungus Treatment Shown Effective in Early Results
Results from a clinical trial show an experimental anti-fungal drug effective in 2 cases of Candida auris infections, a fungus resistant to most other drugs.
-
Biotechs Partner on Gene Silencing in $1.1B Deal
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions.
-
NIH Launches Universal Flu Vaccine Trial
A clinical trial testing a vaccine designed to prevent infections from many influenza strains is underway at National Institutes of Health.
-
Biotechs Join Forces for Off-the-Shelf Stem Cells
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies.
-
Radiation-Antibody Biotech Raises $105M in Venture Funds
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing.
-
Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers
Early results from a clinical trial show a combination of immunotherapy and chemotherapy drugs shrunk tumors in most participants with pancreatic cancer.
-
Genome Editing Biotech Raises $126M in IPO
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock.
-
Respiratory Vaccine Maker Raises $3.4M in Seed Funds
A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials.
-
Start-Up Creating Off-the-Shelf Stem Cell Therapies
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions.
-
NSF Funding Natural Agri-Chemical Technology
A start-up company spun-off from Cornell University is receiving a small business grant to develop in crop plants a natural protection against pathogens.